Humacyte, Inc.
NASDAQ:HUMA
4.68 (USD) • At close January 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 10.79 | 0 | 0 | 0 | 0 | 0.031 | 1.301 | 0.233 | 0.177 | 0.241 | 0.69 | 0.155 | 0.124 | 0.914 | 0.198 | 0.255 |
| Cost of Revenue
| 0 | 1.823 | 1.791 | 3.378 | 1.315 | 1.995 | 2.085 | 2.125 | 2.047 | 14.652 | 2.051 | 0.049 | 0.049 | 0.244 | 15.137 | 13.199 | 14.692 | 11.823 | 14.364 |
| Gross Profit
| 0 | -1.823 | -1.791 | 7.412 | -1.315 | -1.995 | -2.085 | -2.125 | -2.016 | -13.351 | -1.818 | 0.128 | 0.192 | 0.446 | -14.982 | -13.075 | -13.778 | -11.625 | -14.109 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0.687 | 0 | 0 | 0 | 0 | -65.032 | -10.262 | -7.803 | 0.723 | 0.797 | 0.647 | -96.658 | -105.444 | -15.074 | -58.712 | -55.329 |
| Reseach & Development Expenses
| 22.926 | 23.753 | 21.264 | 20.18 | 18.552 | 20.54 | 17.278 | 14.957 | 17.337 | 14.652 | 16.314 | 16.25 | 15.386 | 14.568 | 15.137 | 13.199 | 14.692 | 11.823 | 14.364 |
| General & Administrative Expenses
| 7.307 | 5.746 | 5.314 | 6.002 | 6.07 | 3.084 | 5.234 | 5.833 | 6.188 | 5.18 | 5.682 | 5.554 | 5.398 | 5.391 | 4.787 | 2.597 | 3.435 | 2.724 | 3.257 |
| Selling & Marketing Expenses
| 0 | -1.823 | -1.791 | -3.378 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 7.307 | 3.923 | 3.523 | 2.624 | 6.07 | 3.084 | 5.234 | 5.833 | 6.188 | 5.18 | 5.682 | 5.554 | 5.398 | 5.391 | 4.787 | 2.597 | 3.435 | 2.724 | 3.257 |
| Other Expenses
| 0 | -0.729 | 0 | 0.266 | 0 | 0 | -0.266 | -0.048 | -0.031 | 0 | -0.233 | -1.328 | -1.252 | 0 | -0.155 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 30.233 | 27.676 | 24.787 | 22.804 | 24.622 | 23.624 | 22.512 | 20.79 | 23.494 | 18.531 | 21.763 | 21.627 | 20.543 | 19.269 | 19.769 | 15.672 | 17.213 | 2.724 | 3.257 |
| Operating Income
| -30.233 | -29.499 | -26.578 | -26.182 | -24.622 | -26.731 | -22.512 | -20.79 | -23.494 | -18.531 | -21.763 | -21.627 | -20.543 | -19.269 | -19.769 | -15.672 | -17.213 | -14.349 | -17.366 |
| Operating Income Ratio
| 0 | 0 | 0 | -2.427 | 0 | 0 | 0 | 0 | -757.871 | -14.244 | -93.403 | -122.186 | -85.241 | -27.926 | -127.542 | -126.387 | -18.833 | -72.47 | -68.102 |
| Total Other Income Expenses Net
| -8.969 | -27.164 | -5.318 | 1.076 | -1.373 | 4.025 | -14.457 | 17.07 | -1.787 | 55.399 | 1.931 | 64.212 | -11.02 | 2.071 | -0.532 | -0.54 | -0.547 | -0.529 | -0.308 |
| Income Before Tax
| -39.202 | -56.663 | -31.896 | -25.106 | -25.995 | -22.706 | -36.969 | -3.72 | -25.281 | 36.868 | -19.832 | 42.585 | -31.563 | -17.198 | -20.301 | -16.212 | -17.76 | -14.878 | -17.674 |
| Income Before Tax Ratio
| 0 | 0 | 0 | -2.327 | 0 | 0 | 0 | 0 | -815.516 | 28.338 | -85.116 | 240.593 | -130.967 | -24.925 | -130.974 | -130.742 | -19.431 | -75.141 | -69.31 |
| Income Tax Expense
| 0 | 0 | 1.748 | -28.049 | 1.463 | 1.71 | 24.876 | -17.295 | 0.146 | 1.488 | -3.363 | -67.586 | 7.709 | 1.215 | 0.001 | 16.021 | 17.719 | 0 | 0 |
| Net Income
| -39.202 | -56.663 | -31.896 | -25.106 | -25.995 | -22.706 | -61.845 | 13.575 | -25.427 | 36.868 | -16.469 | 42.585 | -31.563 | -17.198 | -20.301 | -16.212 | -17.76 | -14.878 | -17.674 |
| Net Income Ratio
| 0 | 0 | 0 | -2.327 | 0 | 0 | 0 | 0 | -820.226 | 28.338 | -70.682 | 240.593 | -130.967 | -24.925 | -130.974 | -130.742 | -19.431 | -75.141 | -69.31 |
| EPS
| -0.33 | -0.48 | -0.29 | -0.24 | -0.25 | -0.22 | -0.6 | 0.13 | -0.25 | 0.36 | -0.16 | 0.41 | -0.72 | -0.17 | -0.2 | -5.61 | -1.43 | -0.68 | -0.81 |
| EPS Diluted
| -0.33 | -0.48 | -0.29 | -0.24 | -0.25 | -0.22 | -0.6 | 0.13 | -0.25 | 0.35 | -0.16 | 0.41 | -0.72 | -0.17 | -0.2 | -5.61 | -1.43 | -0.68 | -0.81 |
| EBITDA
| -30.233 | -52.325 | -28.289 | -20.001 | -23.217 | -19.001 | -33.185 | -37.908 | -21.593 | 40.388 | -16.349 | 46.038 | -28.859 | -17.203 | -17.699 | -13.595 | -15.131 | -12.259 | -15.264 |
| EBITDA Ratio
| 0 | 0 | 0 | -2.113 | 0 | 0 | 0 | 0 | -663.742 | -12.459 | -84.515 | -492.469 | -44.71 | -24.929 | -114.181 | -109.629 | -18.83 | -61.914 | -59.859 |